[Neurological aspects of Fabry's disease]. (Q31041350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Neurological aspects of Fabry's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

author name string

G Besson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

C Elziere

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

A Ferrier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

J-M Pinard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

M Hermier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

J Y Artigou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

D P Germain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

French

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

volume

162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

569-580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

A CASE OF “ANGEIO-KERATOMA.”

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Enhanced endothelium-dependent vasodilation in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Variable clinical presentation in lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Vertebrobasilar infarcts in patients with dolichoectatic basilar artery

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease with cerebrovascular complications in two Italian families

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Non-invasive evaluation of arterial involvement in patients affected with Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease: Significance of ultrastructural localization of lipid inclusions in dermal nerves

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease: impaired autonomic function

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease: immunocytochemical characterization of neuronal involvement

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Endothelial markers and homocysteine in patients with classic Fabry disease.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease in childhood

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Chronic meningitis in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Sympathetic and parasympathetic pupillary dysfunction in familial dysautonomia

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

An Atypical Ultrastructural Pattern in Fabry's Disease: A Study on Its Nature and Incidence in 7 Cases

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Urinary Lipid Profiling for the Identification of Fabry Hemizygotes and Heterozygotes

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Involvement of dorsal root ganglia in Fabry's disease.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Methotrexate reduces antibody responses to recombinant human alpha-galactosidase A therapy in a mouse model of Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the alpha-galactosidase A gene and detection of carriers in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

A new phenotype of Fabry disease with intermediate severity between the classical form and the cardiac variant

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry's disease presenting as stroke in a young female

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Nerve conduction studies, electromyography and sympathetic skin response in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry's disease presenting with stroke

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Stroke in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Early renal changes in hemizygous and heterozygous patients with Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Mutation analysis in 11 French patients with Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Avascular necrosis of the femoral head in a patient with Fabry's disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Neuropathy and Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

New insights in cardiac structural changes in patients with Fabry’s disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Relief of pain of Fabry's disease by diphenylhydantoin

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Physiological characterization of neuropathy in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Gene action in the X-chromosome of the mouse (Mus musculus L.)

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Neuropathic pain in Anderson-Fabry disease: pathology and therapeutic options

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Prevalence of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Diagnosis of lysosomal storage disorders: current techniques and future directions.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

The Vascular Dementia of Fabry's Disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Magnetic resonance imaging in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Cerebrovascular complications of Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Selective arterial distribution of cerebral hyperperfusion in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Severe orthostatic hypotension in a female carrier of Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

An Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Pediatric Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Optimisation of the separation of four major neutral glycosphingolipids: application to a rapid and simple detection of urinary globotriaosylceramide in Fabry disease.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Natural history of Fabry disease in males: preliminary observations

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Ultrastructure of muscle and sensory nerve in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Headache Associated With Aseptic Meningeal Reaction as Clinical Onset of Fabry's Disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Functional assessment of A delta and C fibers in patients with Fabry's disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Neurological manifestation of Fabry disease in females

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Clinical manifestation in female Fabry disease patients

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

1 reference

https://api.crossref.org/works/10.1016/S0035-3787(06)75051-2

7 January 2021

10.1016/S0035-3787(06)75051-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710123 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference